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Spontaneous or medically induced reperfusion occurs in up to 70% of patients within
24 h after cerebral ischemia. Reperfusion of ischemic brain tissue can augment the
inflammatory response that causes additional injury. Recently, T cells have been shown
to be an essential part of the post-ischemic tissue damage, and especially IL-17 secreting
T cells have been implicated in the pathogenesis of a variety of inflammatory reactions in
the brain. After stroke, it seems that the innate γδ T cells are the main IL-17 producing
cells and that the γδ T cell activation constitutes an early and mainly damaging immune
response in stroke. Effector mechanism of γδ T cell derived IL-17 in the ischemic brain
include the induction of metalloproteinases, proinflammatory cytokines and neutrophil
attracting chemokines, leading to a further amplification of the detrimental inflammatory
response. In this review, we will give an overview on the concepts of γδ T cells and IL-17
in stroke pathophysiology and on their potential importance for human disease conditions.
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INTRODUCTION
Ischemic stroke is the primary reason for sustained disability and
the third leading cause of death in the western world. In 85% of
these patients, occlusion of an artery in the brain is the cause of
stroke. Early restoration of blood flow (reperfusion) remains the
treatment of choice for limiting brain injury following stroke. The
reperfusion, which enhances the oxygen and glucose content in
the tissue also increases an inflammatory response (Iadecola and
Anrather, 2011). The idea that inflammation causes further brain
injury is supported by a large number of reports that describe
a reduction in infarct size and brain edema in animal models
of stroke that receive blocking antibodies against specific cell
adhesion molecules that mediate leukocyte recruitment (Yilmaz
and Granger, 2008), anti-inflammatory treatment (Sharkey and
Butcher, 1994), and immune deficient animals (Yilmaz et al.,
2006; Hurn et al., 2007; Kleinschnitz et al., 2010; Gelderblom
et al., 2012).
αβ T CELLS AND REGULATORY T CELLS IN STROKE
Compared to resident microglia, infiltrating macrophages and
neutrophils, lymphocytes and NK cells infiltrate the ischemic
hemisphere in small numbers. Nevertheless, T cells have a great
impact on stroke outcome. The initial observation by Yilmaz et al.
that lymphocyte deficient rag1−/− mice are protected from stroke
(Yilmaz et al., 2006) could be extended to mice with severe com-
bined immunodeficiency lacking T cells and B cells (Hurn et al.,
2007) and to CD4+ and CD8+ T cell-deficient animals (Yilmaz
et al., 2006). Direct detrimental mechanisms elicited by αβ T cell
in stroke pathophysiology include CD8+ T cell derived perforin
mediated cytotoxicity (Liesz et al., 2011) and IL-21 secreted by
CD4+ T cells (Clarkson et al., 2014).
The classical activation of αβ T cells requires several coincident
signals: (1) engagement of the antigen receptor; (2) co-
stimulatory receptors; (3) cytokine receptors such IL-2 receptor;
a process requiring at least 3–5 d (Jensen et al., 2008). Mul-
tiple studies using antigen specific mucosal tolerization proto-
cols against myelin antigens suggest the involvement of adaptive
mechanism in stroke pathophysiology. Already in 1997 the group
from Hallenbeck demonstrated that rodents tolerized with myelin
peptides are protected from ischemic stroke (Becker et al., 1997).
Mechanistically the protective effects could be attributed to IL-10
producing T cells (Frenkel et al., 2005) and transforming growth
factor-β1 (Becker et al., 2003).
These classical concepts of T cell activation are challenged
by the observation that detrimental T cell dependent effects
following cerebral ischemia can be observed already 24 h post
stroke, in an antigen independent fashion (Kleinschnitz et al.,
2010). Similarly controversial is the role of regulatory Tregs and
B cells in stroke. Liesz and colleagues showed that endogenous
Tregs are protective in later stages following stroke when the
lesions were small (Liesz et al., 2009) and that their beneficial
functions depend on IL-10 (Liesz et al., 2013). However, a lot of
the observed effects of Tregs cannot be attributed to concepts of
adaptive immunity. For example, an early direct inhibitory effect
of Tregs on the MMP9 production from neutrophils was a recently
suggested mechanism (Li et al., 2013). In this model, transfer
of regulatory Tregs conferred protective effects on the outcome
already on day one after stroke even before Tregs infiltrated the
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FIGURE 1 | Sequential events leading to neutrophil infiltration. First,
release from DAMPs from injured cells activates resident microglia via
PPRs to release proinflammatory factors including TNF-α. Second, IL-23
activates γδ T cells to rapidly secrete IL-17 in the ischemic tissue. Third,
neutrophil infiltration is initiated via IL-17 and TNF-α synergistically induced
expression of CXCL-1 in astrocytes.
ischemic brain. Protective effects could be attributed to program
death-1 ligand 1 (PD-L1) dependent inhibition on MMP9 pro-
duction in neutrophils in the peripheral circulation which then
led to a consecutive protection of the blood brain barrier (Li
et al., 2014). Further studies even challenged the overall concept
of Tregs as endogenous protective immune cell population in
stroke (Ren et al., 2011) and a recent study suggests that Tregs
have an early detrimental role, by inducing dysfunction of the
cerebral microcirculation (Kleinschnitz et al., 2013). While the
data on T cell effects in particular Tregs in stroke is still con-
troversial, it is clear that most of the important immunological
effects are not following classical concepts of adaptive immu-
nity, suggesting an innate like behavior of lymphocytes. In this
line, atypical T cells such as γδ T cell and NK cells are likely
to participate in the early orchestration of the inflammatory
reaction. For NK cells it has been shown that neuronal cell
death is mediated by IFN-γ- and Perforin-dependent pathways
as early as 3 h post reperfusion (Gan et al., 2014). A lot more
data exist on γδ T cell, which we will focus on in the following
section.
BIOLOGY OF γδ T CELLS SUBPOPULATIONS
Like αβ T cells, γδ T cells develop in the thymus using the recom-
binase activated gene product (RAG) for the somatic rearrange-
ment of V (variable), D (Diversity and J (joining) gene segments
of the γ and δ chains of their T cell receptor (TcR) (reviewed
in Raulet, 1989). Compared to αβ TcR, the sets of TcR detected
on γδ T cells are limited. Many γδ subsets, primarily the ones
populating certain tissues such as the epidermis, dermis, intestine,
lungs and uterus are displaying an even higher limitation of
their TcR diversity. These tissue-specific γδ T cell subsets show a
biased use of certain TcR V gene segments. Since some of them
express “invariant” TcRs with identical (canonical) junctional
sequences, they are also named canonical γδ T cells. As reviewed
by Vantourout and Hayday, the limited TcR diversity implies that
these cells recognize either pathogen encoded antigens, that are
likely to be encountered in specific tissues such as the epidermis,
or self-encoded molecules that reflect a dysregulated state of
that tissue (Vantourout and Hayday, 2013). Since these γδ T cell
subsets can be rapidly activated without the requirement of prior
clonal expansion they are also called “innate like” T cells. In
contrast to canonical γδ T cells so-called non-canonical γδ T cells,
which are characterized by an expression of more diverse γδ TcRs,
are homing into secondary lymphoid tissues. Here they make up
a minor fraction of rodent and human T cells after birth (in mice
1–4% of all T cells). In the context of immune responses non-
canonical γδ T cells are capable to participate distant from their
original site of residence, by trafficking to the site of inflamma-
tion in solid organs (reviewed by Korn and Petermann, 2012).
Similar to αβ T cells, γδ T cells can be divided by their cytokine
profile. Mouse γδ T cells which are developing from fetal liver
progenitors undergo functional pre-programming, which leads
to a subpopulation of IL-17 producing Scart-2+ and CCR6+ γδ
T cells on one side and IFN-γ producing NK.1.1+ and CD27+
γδ T cells on the other side. Both subpopulations have an innate
like phenotype, since they can be rapidly activated without prior
clonal expansion (Vantourout and Hayday, 2013). γδ T cells fulfill
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important sentinel functions in the immune system. The ability
of γδ T cells to recognize molecules that are rapidly displayed
after stress without requiring extensive clonal expansion permits
γδ T cells to participate in early stages of immune responses.
In such scenarios γδ T cells act in parallel with cells of the
innate immune system as sensors of dysregulation. γδ T cells
may respond to classical signals of the adaptive immune system
or to cytokine signals and either Toll-like receptor (TLR) or
dectin stimuli in the absence of TcR ligation. Activation of the
γδ TcR can occur through major histocompatibility complex
(MHC)-related and unrelated TcR ligands, which are including
foreign- and self-antigens. This allows γδ T cells to respond
to infection and sterile tissue dysregulation such as ischemia.
Beside TcR dependent mechanisms γδ T cell activation can be
mediated through engagement of the activating natural killer
receptors (NKRs) such as NK group 2 member D (NKD2D),
by patter recognition receptors including TLRs (reviewed by
Bonneville et al., 2010) and through cytokines such as IL-1β
and/or IL-23 (Sutton et al., 2009). The constitutive expression
of IL-23 and IL-1β receptors by γδ T cells assures this rapid
responsiveness. Within hours upon activation and without prior
expansion systemic γδ T cells can express high levels of effector
cytokines, such as IFN-γ, IL-17, TNF-α and granzymes. In addi-
tion, γδ T cells are capable of producing numerous chemokines
and regulatory factors including IL-13 and insulin-like-growth
factor 1 (IGF-1), allowing them to interact with other immune
cells, such as B cells and αβ T cells in the afferent phase of the
immune response. Regarding the cellular interplay between γδ
T cells and innate immune cells neutrophils play a central role.
Once activated, γδ T cells can stimulate the release of potent
chemoattractants for neutrophils. In this respect, γδ T cells were
recently shown to be the primary sources of the neutrophil-
attracting IL-17 in mouse models of infection (Shibata et al.,
2007), hypersensitivity (Simonian et al., 2009) and autoimmunity
(Roark et al., 2007). Often the activation of the innate immune
system results in a feed back loop that increasingly stimulates γδ
T cells.
γδ T CELLS AS SENSORS OF TISSUE DAMAGE IN STROKE
Stroke resembles classical features of a “sterile inflammation”,
which is characterized by a inflammation in response to tissue
disruption without the involvement of pathogenic microorgan-
isms (See Figure 1; Chen and Nuñez, 2010). Sterile inflam-
mation shares similar mechanisms with inflammation during
infection. Receptors essential for sensing microorganisms are
collectively called pattern recognition receptors (PPRs). PRRs
sense conserved structural moieties that are found in microorgan-
isms and are often called pathogen-associated molecular patterns
(PAMPs) (for review see Chen and Nuñez, 2010). Following
ligand recognition these receptors activate downstream signal-
ing pathways, such as the nuclear factor-κb (NF-κb), mitogen-
activated protein kinase (MAPK) and type I interferon pathways,
which result in the upregulation of pro-inflammatory cytokines
and chemokines that are important in inflammatory responses.
In non-infectious conditions immune cells can be activated via
recognition of endogenous material by PPRs. These endoge-
nous molecules have been named danger-associated molecular
patterns (DAMPs). Under physiological conditions these DAMPs
are localized intracellularly. Under conditions of apoptotic cells
death, cells are cleared immunologically silent without significant
release of DAMPs into the extracellular environment. In contrast,
necrosis following ischemia leads to loss of cell integrity and
release of the cell content into the extracellular space. DAMPs
derived from necrotic cells include the chromatin-associated pro-
tein high-mobility group box 1 (HMGB1), heat shock proteins
(HSPs), mitochondrial peptides and purine metabolites, such as
adenosine triphosphate (ATP) and uric acid (reviewed by Chen
and Nuñez, 2010 and Shen et al., 2013). Consecutively, activated
receptors and signaling pathways include TLR2/4/9, CD24, CD44,
NLRP3, formyl peptide receptor 1, RAGE and IL-1 receptor. In
the context of stroke DAMPs are massively released into the
extracellular compartment. In stroke several pathways have been
described, including TLR2/4, CD38, P2X7 and RAGE, which are
associated with an worsened outcome (Liu et al., 2007; Tang
et al., 2008; Choe et al., 2011; Arbeloa et al., 2012). As we
discussed above γδ T cells can be activated directly by DAMPs
via TLR1/2 and dectin receptors and cytokines, such as IL-1β
and IL-23 (Martin et al., 2009; Sutton et al., 2012). Following
stroke, there is clear evidence that IL-23 activates IL-17 pro-
duction in γδ T cells (Shichita et al., 2009). Even though it is
likely that further signals via TcR and TLR/dectin receptors are
necessary to fully activate γδ T cells, the actual experimental data
is outstanding.
EFFECTOR MECHANISMS OF γδ T CELLS IN STROKE
Several papers have shown a significant contribution of γδ T cells
and IL-17 in stroke and other conditions of central nervous
system inflammation (Kebir et al., 2007; Shichita et al., 2009;
Caccamo et al., 2011; Gelderblom et al., 2012). In ischemia
reperfusion injury of the brain we and others have observed a
pathogenic role of γδ T cells, which can be detected in ischemic
brain tissue as early as 6 h post ischemia (Shichita et al., 2009;
Gelderblom et al., 2012). Effector mechanisms of γδ T cells
in stroke primarily depend on their IL-17 production. In
stroke, synergistic stimulation of astrocytes by IL-17 and TNF-α
induces a massive induction of neutrophil attracting chemokines
including CXCL-1 (Gelderblom et al., 2012), resulting in a
subsequent neutrophil infiltration, which is leading to an
increased tissue damage. Activated macrophages and microglia
are secreting high amounts of TNF-α in the ischemic tissue.
In the presence of the TNF-α rich milieu the additional IL-17
signal leads to the rapid increase of CXCL-1 via a stabilizing
effect on the CXCL-1 RNA in astrocytes. Blocking either signal,
IL-17 or the CXCL-1/CXCR2-axis, results in a robust reduction
in infarct size and a significant improved neurological outcome.
Even if an anti-IL-17 antibody is administered 6 h after stroke,
neutrophil invasion can be blocked (Gelderblom et al., 2012).
Neutrophil independent effects of IL-17 secreted by γδ T cells
in stroke include the induction of MMP3 and MMP9 which
are associated with blood brain barrier breakdown (Shichita
et al., 2009; Gelderblom et al., 2012). Other potential effector
functions of γδ T are engagement of death inducing receptors
such as CD95 or TNF-related apoptosis-inducing ligand receptors
(TRAILR), and the release of cytotoxic effector molecules, such
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as perforin and granzymes (See Figure 1). Molecular signals
directing γδ T cell into the ischemic brain is another unresolved
issue. γδ T cell subpopulations can be divided by Scart-2 and
CCR6 vs. NK.1.1 and CD27 expression into IL-17 vs. IFN-γ
producing T cells, respectively. The functional relevance of the
CCR6 expression on IL-17 producing γδ T cells is supported by
experimental data, showing that the migration of γδ T cells into
the inflamed liver depends on the CCL20/CCR6 axis (Hammerich
et al., 2014). Nevertheless, in stroke it is so far unclear which
chemokines/chemokine receptors are essential for the entry of γδ
T cells into the ischemic brain and which γδ T cell subpopulations
are migrating into the ischemic brain.
ROLE OF γδ T CELLS IN HUMAN STROKE PATHOPHYSIOLOGY
Most of the data on inflammation in stroke is derived from
studies in rodent models. These models have several drawback,
including differences between the immune system of rodents
and humans. Further, the vast majority of stroke patients are
older that 65 and are characterized by co-morbidities, which
are not reflected in rodent models (Heuschmann et al., 2010).
Despite these discrepancies, results from post-mortem and imag-
ing studies in human stroke demonstrate that a rapid activation
of the resident and systemic immune system are hallmarks of
human stroke pathophysiology (Mena et al., 2004; Price et al.,
2004; Thiel and Heiss, 2011). Similar to experimental stroke,
neutrophils are recruited into the ischemic brain within 24 h
after symptom onset (Chuaqui and Tapia, 1993; Price et al.,
2004) and microglia undergo rapid activation in the infarct
core but also remote areas such as fiber tracts or relay nuclei
(Thiel and Heiss, 2011). These findings let to several clinical
trials targeting neutrophils in human stroke. Studies employing
inhibitors of the neutrophil—endothelial cell interaction includ-
ing CD18 and ICAM-1 were conducted, none of them show-
ing favorable results on the clinical outcome parameters (del
Zoppo, 2010). Nevertheless, the immunological understanding
of the post ischemic inflammatory response was limited when
these human trials were designed. Regarding our current under-
standing of the stroke induced inflammation IL-17 seems to
be promising target. Infiltration by γδ T cells and secretion of
IL-17 have been demonstrated in ischemic pathological human
brain tissue (Li et al., 2005; Gelderblom et al., 2012). Similarly,
IL-17 induced downstream pathways can be found. The IL-17
presence in the ischemic brain is early and short-lived and has
most likely only pro-inflammatory effects. Therefore a short anti-
IL-17 intervention could be beneficial without producing side
effects, for example enhancing the systemic immune suppres-
sion. Recent data from human clinical trials with humanized
neutralizing IL-17A antibodies in patients with autoimmune
disease showed that treatment is well tolerized and effective
(Hueber et al., 2010).
SUMMARY
Inflammation can enhance ischemic damage and lymphocytes
seem to be important component of this process. Interestingly, the
classical concepts of adaptive immune responses do not explain
all observed effects. Several innate like features of lymphocytes
dominate the early pro-inflammatory events. Particularly atypical
T cells such as γδ T cells could explain some of these discrepancies
and targeted treatment against their signature cytokine IL-17
might be a promising treatment option.
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